Sep 10, 2019 / 04:55PM GMT
Vikram Purohit - Morgan Stanley, Research Division - Equity Analyst
Welcome, everyone. My name is Vikram Purohit. I'm one of the biotech analysts here at Morgan Stanley. And before we start our chat with Incyte, I just need to let everyone know that for all important disclosures, including personal holding disclosures and Morgan Stanley disclosures, all of those appear on the Morgan Stanley public website at www.morganstanley.com/researchdisclosures, or at the registration desk.
So with that, happy to have with me on the stage, the Chief Medical Officer and Chief Financial Officer from Incyte, Steven Stein and Christiana Stamoulis. Welcome.
So before we get into specific program and financials-related Q&A, maybe you can take a minute for some opening remarks and we'll go from there.
Christiana Stamoulis - Incyte Corporation - Executive VP & CFO
Sure. Happy to start with an update on our progress in 2019. 2019 has been so far a year of strong
Incyte Corp at Morgan Stanley Healthcare Conference Transcript
Sep 10, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers